Literature DB >> 22696698

Acute phosphate nephropathy: a cause of chronic kidney disease.

Jessica Weiss1, Micah L Thorp.   

Abstract

Acute phosphate nephropathy occurs whenever a patient with renal dysfunction is exposed to high doses of phosphate. Bowel purgative agents are a common source of high doses of sodium phosphate and are widely used as bowel preparation agents prior to colonoscopy due to their efficacy and tolerability. Oral sodium phosphate (OSP) preparations used to prepare patients for colonoscopy may be a cause of acute and chronic kidney disease (CKD). CKD associated with OSP agents is the result of nephrocalcinosis, or calcium phosphorus crystal deposition in the renal parenchyma leading to interstitial disease. It is often irreversible and progressive in nature. The authors report a case of CKD which presented with non-specific symptoms weeks after use of an OSP agent as part of a bowel preparation regimen. Renal biopsy confirmed nephrocalcinosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22696698      PMCID: PMC3089928          DOI: 10.1136/bcr.04.2010.2876

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: a forgotten menace.

Authors:  K K Ma; C S H Ng; L M Mui; K C Chan; E K W Ng; S C S Chung
Journal:  Endoscopy       Date:  2003-08       Impact factor: 10.093

2.  Risk of kidney injury following oral phosphosoda bowel preparations.

Authors:  Steven M Brunelli; James D Lewis; Meera Gupta; Sherif M Latif; Mark G Weiner; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

3.  Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy.

Authors:  Annette Beyea; Clay Block; Alan Schned
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

4.  The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy.

Authors:  Anand Khurana; Luciana McLean; Sheree Atkinson; Charles J Foulks
Journal:  Arch Intern Med       Date:  2008-03-24

Review 5.  Oral sodium phosphate catharsis and acute renal failure.

Authors:  M Ahmed; P Raval; G Buganza
Journal:  Am J Gastroenterol       Date:  1996-06       Impact factor: 10.864

6.  Evidence of calcium phosphate supersaturation in the loop of Henle.

Authors:  J R Asplin; N S Mandel; F L Coe
Journal:  Am J Physiol       Date:  1996-04

7.  Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine.

Authors:  D A Lieberman; J Ghormley; K Flora
Journal:  Gastrointest Endosc       Date:  1996-05       Impact factor: 9.427

8.  A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing.

Authors:  John F Johanson; John W Popp; Lawrence B Cohen; Sandra R Lottes; William P Forbes; Kelli Walker; Edwin Carter; Bing Zhang; Martin Rose
Journal:  Am J Gastroenterol       Date:  2007-06-15       Impact factor: 10.864

9.  Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing.

Authors:  Glen S Markowitz; Samih H Nasr; Philip Klein; Herman Anderson; Jay I Stack; Lloyd Alterman; Barbara Price; Jai Radhakrishnan; Vivette D D'Agati
Journal:  Hum Pathol       Date:  2004-06       Impact factor: 3.466

10.  Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol.

Authors:  Stefan Russmann; Lois Lamerato; Aditya Marfatia; Stephen P Motsko; John C Pezzullo; Gregory Olds; Judith K Jones
Journal:  Am J Gastroenterol       Date:  2007-10-26       Impact factor: 10.864

View more
  2 in total

1.  Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification.

Authors:  Neil J Paloian; Elizabeth M Leaf; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2016-03-09       Impact factor: 10.612

Review 2.  A comparative review of use of sulphate and phosphate salts for colonoscopy preparations and their potential for nephrotoxicity.

Authors:  Bruno Moulin; Thierry Ponchon
Journal:  Endosc Int Open       Date:  2018-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.